Great Lakes Advisors, LLC Acadia Pharmaceuticals Inc Transaction History

Great Lakes Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $9.36 Million - $13.2 Million	-482,666 Closed	0 $0
Q1 2021 May 03, 2021	BUY	$25.02 - $54.99 $804,443 - $1.77 Million	32,152 Added 7.14%	482,666 $12.5 Million
Q4 2020 Feb 09, 2021	BUY	$41.04 - $56.79 $18.5 Million - $25.6 Million	450,514 New	450,514 $24.1 Million
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $2.9 Million - $4.64 Million	-202,452 Closed	0 $0
Q3 2018 Nov 30, 2018	SELL	$13.03 - $21.81 $150,118 - $251,273	-11,521 Reduced 5.38%	202,452 $4.2 Million
Q2 2018 Aug 13, 2018	BUY	$15.07 - $22.34 $3.22 Million - $4.78 Million	213,973 New	213,973 $3.27 Million

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Great Lakes Advisors, LLC with notifications on news.